Topic · Oncology
CAR-T cell therapy research
CAR-T cell therapy research is a research topic within Oncology. Science Explorer counts 48k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on Chimeric Antigen Receptor (CAR) T cell therapy, a form of immunotherapy that uses genetically engineered T cells to target and destroy cancer cells. The papers cover various aspects of CAR T cell therapy, including its application in treating leukemia, lymphoma, and solid tumors, the management of cytokine release syndrome associated with this therapy, and the long-term efficacy and safety of CAR T cell treatment.
- CAR T Cells
- Chimeric Antigen Receptor
- T Cell Therapy
- Leukemia
- Lymphoma
- Immunotherapy
- Cytokine Release Syndrome
- Tumor Regression
- Adoptive Cell Transfer
- Cancer Immunotherapy
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 4.9k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +53% the tick is no change
- Largest producer
United States
49% of the 10 largest, 2022-now
Drawing this view